Elevance Health, Inc. (ELV)

429.69 USD-0.05%close 2026-11-13Financial Services
Gurus hold10popularity #37 of 1921
Net buying (quarter)−$95.0M4 buying · 4 selling
Market Cap$92.84B52 Week Range: 280.74 – 445.28
P/E (TTM)Price/Earnings: share price over annual profit — what you pay per $1 of earnings. Compare within the sector.18.25Dividend Yield: 1.60%
The live quote provider is unreachable; the last known close is shown.

Elevance Health, Inc. (ELV) is not among the 30 most-held stocks of the tracked superinvestor set. Price 429.69 USD; market cap $92.84B.

Guru Ownership

Popularity rank#37 of 1,921 securities
gurus hold it10
Net activity this quarter−$95.0M

Guru count: the consensus-panel funds (wide books such as Citadel or Renaissance excluded) holding the stock at quarter end; the header and the history table use the same definition.

What changed this quarter
$99.1M · 1 new buys · 3 added $194.1M · 4 reduced · 0 sold out4 net buyers · 4 net sellers
Top 5 by conviction
Top 5 by value
Harris Associates (Bill Nygren)$1.90BAdded +2.7%
First Eagle Investment Management$1.62BAdded +1.4%
Baupost Group (Seth Klarman)$493.1MUnchanged 0.0%
Baillie Gifford$418.9MReduced -7.6%
Ruane, Cunniff & Goldfarb$378.8MReduced -29.4%
Ownership by quarter · 72 funds with stored history
Report forgurus hold itTotal ValueAvg Weight
2016-09-301$701.4M5.0%
2016-12-317$2.73B1.6%
2017-03-317$2.95B1.7%
2017-06-308$2.77B1.6%
2017-09-308$2.74B1.5%
2017-12-318$2.84B1.3%
2018-03-318$2.65B1.3%
2018-06-307$2.45B1.3%
2018-09-307$2.70B1.4%
2018-12-318$2.40B1.3%
2019-03-319$4.38B2.4%
2019-06-309$4.59B2.3%
2019-09-309$3.80B2.0%
2019-12-3110$4.54B1.9%
2020-03-3110$2.24B1.0%
2020-06-306$1.80B0.9%
2020-09-307$1.94B0.8%
2020-12-317$2.14B0.9%
2021-03-318$2.81B1.3%
2021-06-308$3.24B1.5%
2021-09-308$3.14B1.4%
2021-12-317$4.10B1.9%
2022-03-318$4.21B1.9%
2022-06-308$4.35B2.2%
2022-09-308$4.35B2.4%
2022-12-318$4.50B2.5%
2023-03-319$3.88B2.0%
2023-06-309$3.58B1.9%
2023-09-309$2.94B1.9%
2023-12-318$3.22B2.2%
2024-03-318$3.49B2.4%
2024-06-308$3.69B2.4%
2024-09-307$3.51B2.4%
2024-12-318$3.49B1.9%
2025-03-318$4.18B2.6%
2025-06-308$3.83B2.6%
2025-09-308$4.07B3.0%
2025-12-318$4.89B3.1%
2026-03-319$3.88B2.4%
2026-06-3010$5.03B2.5%

Price & valuation

Prev Close429.9
Open—
Day Range—
52 Week Range280.74 – 445.28
Volume—
Avg Volume (3M)—
Market Cap$92.84BSEC 10-Q, 10/15/2026
BetaVolatility vs the market. Above 1: swings harder than the index.0.412 years, weekly, vs SPY
P/E (TTM)Price/Earnings: share price over annual profit — what you pay per $1 of earnings. Compare within the sector.18.25SEC 10-Q, 09/30/2026
EPS (TTM)Annual net profit per share.23.54SEC 10-Q, 09/30/2026
Dividend YieldAnnual dividend over share price.1.60%SEC 10-Q, 09/30/2026

Pro Feature

This section is exclusive to Fundocap Pro. Full holdings tables, consensus trades, ownership analysis, backtests and exports unlock with Pro.

Upgrade to Pro

About

SectorFinancial Services
Industry—
Employees—
Website—

Frequently Asked Questions

Which superinvestors own ELV?

Elevance Health, Inc. (ELV) is not among the 30 most-held stocks of the tracked superinvestor set.

Is institutional sentiment on ELV bullish or bearish?

ELV is not among the 30 most-held stocks of the superinvestor set, so net buyer/seller counts are not computed for it.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.